Performance of Abbott ARCHITECT® CORIE-M™ assay for the US

被引：0
|
作者：
Paradowski, M.
Grasso, K.
Demers, L.
Heffner, J.
Dubler, R.
Kramer, C.
Hoffman, A.
Herrmann, R.
Bartko, K.
Galvani, K.
Fei, H.
Li, C.
Rios, W.
Williams, G.
Mohammad, A. A.
机构：
[1] Abbott Labs, Abbott Pk, IL 60064 USA
[2] Penn State Univ, Milton S Hershey Med Ctr, Hershey, PA 17033 USA
[3] Wisconsin Co Biomed Res, Milwaukee, WI USA
[4] Univ Texas, Med Branch, Galveston, TX 77550 USA
来源：
CLINICAL CHEMISTRY | 2007年 / 53卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
B-18
引用
收藏
页码：A58 / A58
页数：1
相关论文
共 50 条
  • [31] Analytical evaluation of the new Abbott ARCHITECT Cyclosporine assay
    Edwards, M.
    Haverstick, D. M.
    Sluss, P. M.
    Young, J.
    Schmidt, E.
    Kettlety, T.
    CLINICAL CHEMISTRY, 2008, 54 (06) : A19 - A19
  • [32] Multisite Analytical Evaluation of the Abbott ARCHITECT Cyclosporine Assay
    Wallemacq, Pierre
    Maine, Gregory T.
    Berg, Keith
    Rosiere, Thomas
    Marquet, Pierre
    Aimo, Giuseppe
    Mengozzi, Giulio
    Young, Julianna
    Wonigeit, Kurt
    Kretschmer, Robert
    Wermuth, Bendicht
    Schmid, Rainer W.
    THERAPEUTIC DRUG MONITORING, 2010, 32 (02) : 145 - 151
  • [33] Next generation activated AST assay application for the Abbott AEROSET®, Abbott ARCHITECT® c8000®, and Abbott ARCHITECT® c16000® systems
    Colberg, S.
    Kuykendall, K.
    Thillen, R.
    Combs, B.
    CLINICAL CHEMISTRY, 2007, 53 (06) : A33 - A33
  • [34] Performance characteristics of the enzymatic Abbott Architect HbA1c whole blood assay
    Ajubi, Nasser E.
    Kross-Brion, Jesmine
    Newton, Cora J.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2014, 52 (12) : E283 - E285
  • [35] An automated assay for measurement of total homocysteine on the Abbott ARCHITECT® instrument
    Dashfal, D. J.
    Mueller, C.
    Carlow, D.
    Yoshimura, T.
    Craig, D.
    Ferguson, L.
    Campbell, G.
    Eng, E.
    Sinio, L.
    Zabala, P.
    Carlson, C.
    CLINICAL CHEMISTRY, 2007, 53 (06) : A12 - A12
  • [36] A comparative study of the Abbott ARCHITECT® Anti-HCV assay
    Grasso, K.
    Demers, L.
    Heffner, J.
    Attar, B.
    Gill, J.
    Lee, W. M.
    Schiff, E.
    Trotter, J.
    Mazin, A.
    Mo, M.
    Mohammad, A. A.
    CLINICAL CHEMISTRY, 2006, 52 (06) : A42 - A42
  • [37] Development of an assay for C-peptide on the Abbott ARCHITECT analyzer
    Martens, M.
    van Duren, C.
    Veldhuizen, K.
    Dhein, J.
    Eppinger, M.
    Hausmann, M.
    Krack, W.
    Schultess, J.
    Moeckel, M.
    Mueller, C.
    CLINICAL CHEMISTRY, 2007, 53 (06) : A182 - A182
  • [38] Novel Batch pretreatment Procedure for the Abbott ARCHITECT Tacrolimus Assay
    Mukaida, M.
    Hata, N.
    Iyama, S.
    Hayashi, S.
    Hidaka, Y.
    Fukami, H.
    Achiha, M.
    Kawashima, M.
    Hikichi, N.
    CLINICAL CHEMISTRY, 2009, 55 (06) : A253 - A254
  • [39] Validation of the Procalcitonin Assay on the Abbott Architect i1000
    Pagaduan, Jayson, V
    Tam, Estella
    Devaraj, Sridevi
    JOURNAL OF APPLIED LABORATORY MEDICINE, 2019, 3 (06): : 936 - 942
  • [40] Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho
    Bryan, Andrew
    Pepper, Gregory
    Wener, Mark H.
    Fink, Susan L.
    Morishima, Chihiro
    Chaudhary, Anu
    Jerome, Keith R.
    Mathias, Patrick C.
    Greninger, Alexander L.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2020, 58 (08)
12345